Picture of BJ Bio-Tech Development Management Holding logo

BJBJ BJ Bio-Tech Development Management Holding Income Statement

0.000.00%
us flag iconLast trade - 00:00
FinancialsHighly SpeculativeMicro Cap

Annual income statement for BJ Bio-Tech Development Management Holding, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

2007
June 30th
2008
June 30th
2009
June 30th
R2010
June 30th
2011
June 30th
Period Length:8 M12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUS10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue1.393.13.500
Cost of Revenue
Gross Profit0.0360.3610.527
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses12.13.414.030.5360.499
Operating Profit-10.7-0.308-0.529-0.536-0.499
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-10.7-0.333-0.58-0.597-0.625
Provision for Income Taxes
Net Income After Taxes-10.7-0.333-0.58-0.597-0.625
Net Income Before Extraordinary Items
Extraordinary Items
Net Income-10.7-0.333-0.58-0.786-0.963
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income-10.7-0.333-0.58-0.786-0.963
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-14.5-0.421-0.729-0.712-0.395
Dividends per Share